Načítá se...
The therapeutic efficacy of (177)Lu-DOTATATE/DOTATOC in advanced neuroendocrine tumors: A meta-analysis
BACKGROUND: Somatostatin analog therapies showed great potential for patients suffering advanced neuroendocrine tumors (NETs). This study was aimed to evaluate the therapeutic efficacy of (177)Lu-DOTATATE/DOTATOC ((177)Lu-octreotate/octreotide) peptide receptor radionuclide therapy (PRRT) in advance...
Uloženo v:
| Vydáno v: | Medicine (Baltimore) |
|---|---|
| Hlavní autoři: | , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Wolters Kluwer Health
2020
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7478707/ https://ncbi.nlm.nih.gov/pubmed/32150065 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MD.0000000000019304 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|